Megan Aubin

Title: **Megan Aubin: Innovating Cell Culture Techniques**

Introduction

Megan Aubin, a notable inventor based in Orlando, Florida, has made significant contributions to the field of cell culture through her innovative patent. With her expertise, she is at the forefront of advancements that enhance biological research and applications.

Latest Patents

Megan holds a patent for a groundbreaking invention titled "Method and System for Printing Cells to a Substrate Comprising Cell Adhesive Regions." This innovative method involves culturing cells by printing them onto a specially designed substrate that features both cell adhesive and cell repulsive regions. The cells are suspended in a printing medium to form a cell suspension, which is then precisely placed on the substrate. The technique ensures that the cells adhere only to the designated areas, allowing for the creation of specific cell patterns while maintaining an ideal physiological environment for growth.

Career Highlights

Throughout her career, Megan Aubin has worked with reputable organizations such as the University of Central Florida Research Foundation and Hesperos, LLC. Her work has contributed to the advancement of cell printing technology, paving the way for innovative applications in tissue engineering and regenerative medicine.

Collaborations

Megan has collaborated with esteemed colleagues, including James J. Hickman and Sandra Rothemund, who have further enriched her research endeavors. These collaborations underscore the importance of teamwork in driving innovation in scientific research.

Conclusion

Megan Aubin’s contributions to the field of cell culture through her inventive methods showcase the importance of innovation in science and technology. Her patent not only exemplifies her expertise but also highlights the potential for future advancements in cell biology and related fields. As researchers continue to build upon her work, the impact of her innovations is sure to resonate in the scientific community for years to come.